Johnson & Johnson

JNJ
HealthcareDividend King
$275.21
1.92%Overvalued

Johnson & Johnson (JNJ) is a Healthcare company that currently yields 1.92% — historically overvalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $156.11 and the overvaluation threshold at $206.33. Johnson & Johnson holds a quality score of 50/100 (Average), reflecting 64 consecutive years of dividend growth with a 80% payout ratio. The 5-year dividend CAGR stands at 5.2%.

JNJ Dividend Yield History — Weiss Valuation

Underval. $156.11Overval. $206.33

Distance to undervalued

Entry price is stretched

Needs 43.3% downside to reach the Weiss buy zone

Undervaluation starts near $156.11, where the annual dividend would imply roughly 3.38% yield. That is 1.46% above today's yield.

Buy-zone price

$156.11

Target yield

3.38%

Research checklist

What to clear before buying the yield

Updated Nov 18, 2026

Dividend durability

64Y

Long dividend history supports a deeper look.

Earnings payout

80%

Coverage deserves a closer look in filings.

Cash payout

70%

Free cash flow coverage supports the payment.

Dividend growth

5.2%

Recent growth adds income compounding potential.

What changed

What changed since the last update

2026-11-17 → 2026-11-18

Price

-1.6%

$279.73 → $275.21

Price fell 1.6% since the prior snapshot.

Why Now?

Johnson & Johnson is trading near its historical overvaluation band.

Current yield 1.9% vs historical max 4.9% (40% of maximum).

14 consecutive years without a dividend cut.

Elevated payout ratio of 80%.

What matters now

Read the signal before the headline yield

Valuation is the brake here: the yield is compressed versus its own history.

The 50/100 quality score says the headline yield needs extra skepticism.

Start by checking whether payout coverage and business durability still support the dividend.

JNJ Dividend Income Projection — DRIP Compounder

Dividend Compounder (DRIP)

$

Year 1 Income

$202

Year 10 Income

$398

Yield on Cost

4.1%

Total Income

$2,878

Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.

Track actual vs. projected

See what JNJ dividends you actually received with Sharesight

Dividend income log · Yield on cost · DRIP cost basis · Tax reports

→

More research

Full price history & technical analysis

TradingView ↗

Fundamentals, valuation & analyst ratings

FinViz ↗

Moat rating & analyst fair value

Morningstar ↗

Track dividends received & tax reports

Sharesight ↗

JNJ Dividend Quality Score

Quality Score

50/ 100

Average

Payout Ratio5/25
Dividend Streak20/25
Growth (CAGR 5Y)15/20
Yield vs History0/15
FCF Coverage10/15

Key Metrics

Current Price$275.21
Annual Dividend$5.28
Current Yield1.92%
Yield — Max (10Y)4.86%
Yield — Min (10Y)2.72%
Undervalued Below$156.11
Overvalued Above$206.33
Payout Ratio80.12%
CAGR Dividend 5Y5.2%
CAGR Dividend 10Y5.7%
Years No Cut14y

Invest in JNJ

Check Johnson & Johnson availability and current costs on eToro

Check eToro terms and availability →
Fractional sharesFees vary by countryCapital at risk

DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.

64
consecutive years of dividend growth